Invectys, Inc appoints Biopharma Veteran, Praveen Tyle,...
Invectys, Inc appoints Biopharma Veteran, Praveen Tyle, PhD as President & CEO Houston, TX, USA, May 4, 2021 (GLOBE NEWSWIRE) – Invectys, Inc., a clinical-stage…
Read more
Invectys, Inc appoints Biopharma Veteran, Praveen Tyle, PhD as President & CEO Houston, TX, USA, May 4, 2021 (GLOBE NEWSWIRE) – Invectys, Inc., a clinical-stage…
AACR Annual Meeting 2021 April 10th – 15th 2021 Invectys was at the AACR’s Annual Meeting 2021. Although online, the AACR Annual Meeting still carried…
Invectys well poised to bring its anti-HLA-G CAR-T cells to clinical trials …
The main product of Invectys is a DNA vaccine targeting Telomerase…
The telomerase enzyme functions as part of a large ensemble of proteins and RNA called the telomerase ribonucleoprotein complex.…
Monoclonal antibodies targeting checkpoint inhibitors are hugely important immunotherapy molecules for the treatment cancers…